Cancers 12 (4), 822 (2020)
I think if people are really armed with that information, it makes things a lot easier
For weight management, NICE recommends Wegovy within specialist services for eligible patients with obesity or overweight with weight-related conditions, not specifically for food noise
Among the patients who develop NASH, 1020% will progress to higher-grade fibrosis and approximately 5% will develop overt cirrhosis (14)
More importantly, infection risk increases 300% when reusing needles due to bacterial contamination
How to Taper Off GLP-1 Medications: Stopping, Switching, and Preventing Weight Regain At a glance Weight regain risk / ~two-thirds of lost weight returns within 1 year of abrupt discontinuation (STEP-1 extension) Semaglutide 2.4 mg peak loss / 14.9% mean body weight at 68 weeks (STEP-1, N=1,961) Tirzepatide 15 mg peak loss / up to 20.9% mean body weight at 72 weeks (SURMOUNT-1, N=2,539) SURMOUNT-4 maintenance finding / continuing tirzepatide vs